Ticker
BIO
Analysis
Biome Australia Ltd (BIO) Stock Analysis
Biome Australia Ltd investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to BIO.
Biome Australia Ltd
Biome Australia Ltd investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to BIO.
Stock profile
Asset type
Stock
Market cap
$43.9M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Currency
AUD
Ticker listings
Biome Australia Ltd may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.
- BIO primary listing
Latest Biome Australia Ltd news
Biome Signs Australian Manufacturing Agreement
Biome Signs Australian Manufacturing Agreement
BMB18 clinical trial expands to dual site
BMB18 clinical trial expands to dual site
Probiotical Exclusive Supply Agreement Extended
Probiotical Exclusive Supply Agreement Extended
Patent Application Filed for Probiotic Strain BMB18
Patent Application Filed for Probiotic Strain BMB18
Biome First Half FY26 Results and Highlights
Biome First Half FY26 Results and Highlights
Research sections
Valuation
Review valuation context for Biome Australia Ltd.
Future growth
Review future growth context for Biome Australia Ltd.
Past performance
Review past performance context for Biome Australia Ltd.
Financial health
Review financial health context for Biome Australia Ltd.
Dividend
Review dividend context for Biome Australia Ltd.
Management
Review management context for Biome Australia Ltd.
Ownership
Review ownership context for Biome Australia Ltd.
Other information
Review other information context for Biome Australia Ltd.
Community
Review community context for Biome Australia Ltd.